Home
Account
Research Tools
Educate
Contribute
News
Sectors
Premium
About Us
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Chart School
Tutorials
Learning Center
Glossary
Submit Article
Join Blog Network
Rate Broker
Rate Software
Earnings
Dividend
Management Changes
M&A
Analyst
FDA
IPO
About Us
Contact Us
Advertise With Us
Editorial Staff
Terms and Conditions
Privacy Policy
iStock Rating
F
Details...
Enter Symbol
Medarex, Inc. (NASDAQ: MEDX)
Sector: Medical
Current Price :
$16.02
52 Week Low
$3.41
52 Week High
$16.02
Company
Overview
Research Notes
Company Profile
Competitors
Community
Wiki
Stock Sentiment
Whisper Estimates
Enter Estimates
Message Board
Analysis
Related News
Blog Articles
Press Releases
Charts
Technical Charts
Analyst
Analyst Ratings
Analyst Estimates
Sales Estimates
Ratios
Financial Ratios
Technicals
Shares Outstanding:
128M
Market Cap:
$2.05B
Avg Volume:
5304026
P/E Ratio:
-0.010
PEG Ratio:
-0.010
Split:
On 10/19/2000 medx split by factor of 2.000
Trade now with
1m
3m
6m
1y
2y
Opinion and Analysis
Pharma & Biotech Stock Review - April 2010 - Industry Outlook
Apr 28, 2010 04:52 PM |
ABT
,
ACL
,
ACOR
,
AMGN
,
BBI
,
BIIB
Big Pharma And Biotech - Industry Outlook
Nov 09, 2009 06:03 PM |
ABT
,
ACL
,
ACOR
,
ALKS
,
AZN
,
BBI
Celldex Therapeutics (NASDAQ: CLDX): Plenty of Cash and Pending Clinical Catalysts
Oct 19, 2009 10:24 PM |
BMY
,
CLDA
,
CRGN
,
GSK
,
MEDX
Our Outlook for Health-Care Stocks
Oct 01, 2009 07:00 PM |
A
,
BMY
,
COV
,
DHR
,
GE
,
JNJ
Access Pharma (OTC: ACCP.OB): MuGard, Pipeline Makes for Appealing Acquisition Possibilities
Sep 29, 2009 03:36 PM |
ACCP
,
ALTH
,
BBI
,
BIIB
,
CTIC
,
MEDX
More Articles on MEDX..
Market News
More News on MEDX..
Press Releases
More Press Releases on MEDX..
SEC Filings
More SEC Filings on MEDX..
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
MEDX
Compare to S&P
YTD
186.38 %
151.77 %
4 Weeks
0.44 %
-3.87 %
12 Weeks
113.35 %
95.03 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
-6.25 %
EPS Growth in Last Year:
12.82 %
Sales Growth in Last Quarter:
79.95 %
Sales Growth in Last Quarter:
95.79 %
More...
Fundamental data is provided by
Zacks Investment Research
, and Commentary, news and Press Releases provided by YellowBrix and
Quotemedia
. Advertisement partners
Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##